Loading stock data…
SI
$13.22+0.02 (+0.15%)
Market ClosedLast close May 11
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$13.22
Potential Upside
5%
Whystock Fair Value$13.88
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$282.66M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.67%
Volume
Today's trading volume
59,135
Recent News
Viatris (VTRS) Q1 Earnings and Revenues Surpass Estimates
Viatris (VTRS) delivered earnings and revenue surprises of +13.46% and +4.84%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates
Establishment Labs (ESTA) delivered earnings and revenue surprises of -40.35% and +4.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of +80.00% and +1.52%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Shoulder Innovations Q4 Earnings Call Highlights
Shoulder Innovations (NYSE:SI) executives told investors the company exited 2025 with accelerating commercial momentum, highlighted by rapid revenue growth, expanding surgeon adoption, and continued investment in new products and enabling technologies. Fourth-quarter and full-year financial results
Billionaire Chinese trader bets on silver collapse with $300 million wager
Investing.com -- A billionaire Chinese trader known for profiting from gold’s record rally has placed a massive bet against silver, with a position now worth almost $300 million following the metal’s recent price drop.